First Trust Advisors LP Charles River Laboratories International, Inc. Transaction History

First Trust Advisors LP

  • $108 Billion
  • Q1 2025

A detailed history of First Trust Advisors LP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 127,352 shares of CRL stock, worth $17.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
127,352
Previous 115,483 10.28%
Holding current value
$17.4 Million
Previous $21.3 Million 10.08%
% of portfolio
0.02%
Previous 0.02%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
BUY
$150.52 - $190.14 $1.79 Million - $2.26 Million
11,869 Added 10.28%
127,352 $19.2 Million
Q4 2024

Feb 13, 2025
BUY
$178.58 - $220.69 $7.46 Million - $9.22 Million
41,788 Added 56.7%
115,483 $21.3 Million
Q3 2024

Nov 13, 2024
BUY
$187.96 - $245.29 $265,775 - $346,840
1,414 Added 1.96%
73,695 $14.5 Million
Q2 2024

Aug 13, 2024
SELL
$206.39 - $268.73 $4.85 Million - $6.32 Million
-23,503 Reduced 24.54%
72,281 $14.9 Million
Q1 2024

May 13, 2024
SELL
$203.52 - $273.43 $44.8 Million - $60.2 Million
-219,988 Reduced 69.67%
95,784 $26 Million
Q4 2023

Feb 13, 2024
SELL
$164.52 - $238.84 $4.18 Million - $6.07 Million
-25,421 Reduced 7.45%
315,772 $74.6 Million
Q3 2023

Nov 13, 2023
SELL
$194.44 - $217.61 $6.56 Million - $7.34 Million
-33,728 Reduced 9.0%
341,193 $66.9 Million
Q2 2023

Aug 14, 2023
BUY
$183.71 - $210.25 $12.3 Million - $14.1 Million
67,112 Added 21.8%
374,921 $78.8 Million
Q1 2023

May 15, 2023
BUY
$191.89 - $259.92 $2.22 Million - $3.01 Million
11,586 Added 3.91%
307,809 $62.1 Million
Q4 2022

Feb 09, 2023
BUY
$197.11 - $250.07 $5.74 Million - $7.28 Million
29,098 Added 10.89%
296,223 $64.5 Million
Q3 2022

Nov 14, 2022
BUY
$182.44 - $250.54 $13.9 Million - $19 Million
75,942 Added 39.72%
267,125 $52.6 Million
Q2 2022

Aug 12, 2022
BUY
$204.13 - $302.4 $317,013 - $469,627
1,553 Added 0.82%
191,183 $40.9 Million
Q1 2022

May 13, 2022
SELL
$255.51 - $362.11 $23.3 Million - $33.1 Million
-91,371 Reduced 32.52%
189,630 $53.8 Million
Q4 2021

Feb 08, 2022
SELL
$351.38 - $448.68 $7.74 Million - $9.88 Million
-22,017 Reduced 7.27%
281,001 $106 Million
Q3 2021

Nov 15, 2021
SELL
$372.64 - $458.3 $8.25 Million - $10.1 Million
-22,135 Reduced 6.81%
303,018 $125 Million
Q2 2021

Aug 16, 2021
SELL
$294.17 - $371.65 $11.2 Million - $14.1 Million
-38,059 Reduced 10.48%
325,153 $120 Million
Q1 2021

May 14, 2021
SELL
$249.67 - $299.48 $11.5 Million - $13.8 Million
-46,089 Reduced 11.26%
363,212 $105 Million
Q4 2020

Feb 02, 2021
SELL
$222.0 - $252.62 $28.8 Million - $32.7 Million
-129,564 Reduced 24.04%
409,301 $102 Million
Q3 2020

Nov 05, 2020
SELL
$175.56 - $226.45 $8.32 Million - $10.7 Million
-47,389 Reduced 8.08%
538,865 $122 Million
Q2 2020

Jul 22, 2020
BUY
$118.84 - $189.72 $945,372 - $1.51 Million
7,955 Added 1.38%
586,254 $102 Million
Q1 2020

May 06, 2020
BUY
$98.9 - $178.34 $12.2 Million - $21.9 Million
122,897 Added 26.99%
578,299 $73 Million
Q4 2019

Feb 03, 2020
SELL
$126.05 - $152.76 $15.6 Million - $18.9 Million
-123,675 Reduced 21.36%
455,402 $69.6 Million
Q3 2019

Nov 04, 2019
SELL
$125.07 - $143.67 $43.5 Million - $50 Million
-347,847 Reduced 37.53%
579,077 $76.7 Million
Q2 2019

Jul 30, 2019
SELL
$123.4 - $148.55 $21.1 Million - $25.4 Million
-171,242 Reduced 15.59%
926,924 $132 Million
Q1 2019

May 09, 2019
SELL
$104.82 - $146.73 $129,243 - $180,918
-1,233 Reduced 0.11%
1,098,166 $160 Million
Q4 2018

Feb 07, 2019
BUY
$105.09 - $137.23 $25.3 Million - $33 Million
240,437 Added 27.99%
1,099,399 $124 Million
Q3 2018

Oct 25, 2018
BUY
$112.11 - $134.54 $34.9 Million - $41.8 Million
310,975 Added 56.75%
858,962 $116 Million
Q2 2018

Aug 02, 2018
SELL
$102.37 - $117.25 $4.11 Million - $4.71 Million
-40,177 Reduced 6.83%
547,987 $61.5 Million
Q1 2018

Apr 23, 2018
BUY
$98.19 - $115.2 $4.05 Million - $4.75 Million
41,196 Added 7.53%
588,164 $62.8 Million
Q4 2017

Feb 08, 2018
SELL
$100.43 - $118.09 $749,107 - $880,833
-7,459 Reduced 1.35%
546,968 $59.9 Million
Q3 2017

Oct 24, 2017
BUY
$96.72 - $109.26 $53.6 Million - $60.6 Million
554,427
554,427 $59.9 Million

Others Institutions Holding CRL

# of Institutions
649
Shares Held
55M
Call Options Held
695K
Put Options Held
809K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $6.93B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email